Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset

Title
Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset
Authors
Keywords
Systemic Lupus Erythematosus, Systemic Lupus Erythematosus Patient, Patient Visit, CXCL10 Expression, Belimumab
Journal
ARTHRITIS RESEARCH & THERAPY
Volume 16, Issue 1, Pages R23
Publisher
Springer Nature
Online
2014-01-25
DOI
10.1186/ar4451

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started